More articles from Editorials and Perspectives

The management of febrile neutropenia in the posaconazole era: a new challenge?
Livio Pagano, Morena Caira, Manuel Cuenca-Estrella

Haematologica Jul 2012, 97 (7) 963-965; DOI: 10.3324/haematol.2012.062166
Optimizing investigator-led oncology research in Europe
Tiziano Barbui, Magnus Björkholm, Alois Gratwohl

Haematologica Jun 2012, 97 (6) 800-804; DOI: 10.3324/haematol.2012.064873
Positron emission tomography/computed tomography surveillance in patients with lymphoma: a fox hunt?
Andrea Gallamini, Lale Kostakoglu

Haematologica Jun 2012, 97 (6) 797-799; DOI: 10.3324/haematol.2012.063909
Towards a joint definition of European hematology
Gert Ossenkoppele, Gareth Evans-Jones, Ulrich Jaeger, Eva Hellström-Lindberg

Haematologica May 2012, 97 (5) 636-637; DOI: 10.3324/haematol.2012.067942
Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities
Luca Arcaini, Davide Rossi

Haematologica May 2012, 97 (5) 638-640; DOI: 10.3324/haematol.2011.058362
Raising hematology’s European voice: the importance of calling yourself a hematologist
Thom Duyvené de Wit, Arndt Borkhardt, Christine Chomienne, Hartmut Döhner, Willem E. Fibbe, Robin Foà, Anton Hagenbeek, Radek C. Skoda, Carin R. Smand, Ulrich Jäger

Haematologica Apr 2012, 97 (4) 476-478; DOI: 10.3324/haematol.2011.057257
Conceiving a hematopoietic stem cell donor: twenty-five years after our decision to save a child
Giuseppe Roberto Burgio, Luigi Nespoli, Rita Maccario, Annapia Verri, Patrizia Comoli, Marco Zecca

Haematologica Apr 2012, 97 (4) 479-481; DOI: 10.3324/haematol.2011.060004
The role of antifungal treatment in hematology
Johan A. Maertens, Marcio Nucci, J. Peter Donnelly

Haematologica Mar 2012, 97 (3) 325-327; DOI: 10.3324/haematol.2012.061952
Activation of the NOTCH1 pathway in chronic lymphocytic leukemia
Valentina Gianfelici

Haematologica Mar 2012, 97 (3) 328-330; DOI: 10.3324/haematol.2012.061721
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance
Oliver Hantschel

Haematologica Feb 2012, 97 (2) 157-159; DOI: 10.3324/haematol.2012.061812

More articles from Editorials and Perspectives

Pages